Current strategies in treating severe contact dermatitis in pediatric patients

Current Allergy and Asthma Reports

Volumn 12, Issue 6, 2012, Pages 599-606

  Fonacier, Luz S ^a   Aquino, Marcella R ^a   Mucci, Tania ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Allergic contact dermatitis; Atopic dermatitis; Children; Diagnosis; Fragrance allergy; Irritant contact dermatitis; Metal allergy; Neomycin allergy; Patch test; Pediatric; Plant allergy; Rubber allergy; Treatment

Indexed keywords

ALLERGEN; AZATHIOPRINE; BALSAM PERU; BETAMETHASONE; BUTIROSIN; CALAMINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; EMOLLIENT AGENT; FRAGRANCE; FRAMYCETIN; GENTAMICIN; IMMUNOMODULATING AGENT; KANAMYCIN; METHOTREXATE; MOMETASONE FUROATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOMYCIN; NICKEL; PAROMOMYCIN; PHENYLENEDIAMINE; RUBBER; STREPTOMYCIN; TACROLIMUS; THIOMERSAL; TOBRAMYCIN;

ABDOMINAL PAIN; ANEMIA; APPLICATION SITE BURNING; APPLICATION SITE PRURITUS; ASTERACEAE; ATOPIC DERMATITIS; BACTERIAL INFECTION; CATARACT; CHILD; CHILD HEALTH CARE; COLITIS; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; CUSHING SYNDROME; DIABETES MELLITUS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG CROSS REACTIVITY; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG RESPONSE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; GROWTH RETARDATION; HEMATOLOGIC DISEASE; HERPES SIMPLEX; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IRRITANT DERMATITIS; LEUKOPENIA; LIVER TOXICITY; LYMPHOCYTOPENIA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; NON MELANOMA SKIN CANCER; OSTEOLYSIS; PATCH TEST; PHOTOTHERAPY; PHYSICAL EXAMINATION; PLANT DERMATITIS; POISON IVY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SKIN ALLERGY; STAPHYLOCOCCUS INFECTION; THROMBOCYTOPENIA; VIRUS INFECTION; VOMITING;

ADRENAL CORTEX HORMONES; ALLERGENS; CHILD; COSMETICS; DERMATITIS, ATOPIC; DERMATITIS, CONTACT; DIAGNOSIS, DIFFERENTIAL; FOOD HYPERSENSITIVITY; GLUCOCORTICOIDS; HUMANS; NICKEL; PHYSICAL EXAMINATION; PRESERVATIVES, PHARMACEUTICAL;

EID: 84870599597     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-012-0305-0     Document Type: Review

References (71)

1. Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55(3):490-500. (Pubitemid 44209289)
2. Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr. 2006;18(4):385-90. (Pubitemid 44258995)
3. Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children-a United States based study. Pediatr Dermatol. 2008;25(5):520-7.
4. Sharma VK, Asati DP. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol. 2010;76(5):514-20.
5. Kutting B, Brehler R, Traupe H. Allergic contact dermatitis in children: strategies of prevention and risk management. Eur J Dermatol. 2004;14(2):80-5. (Pubitemid 38510022)
6. Giordano-Labadie F, Rance F, Pellegrin F, Bazex J, Dutau G, Schwarze HP. Frequency of contact allergy in children with atopic dermatitis: results of a prospective study of 137 cases. Contact Dermatitis. 1999;40(4):192-5. (Pubitemid 29134565)
7. Herro EM, Matiz C, Sullivan K, Hamann C, Jacob SE. Frequency of contact allergens in pediatric patients with atopic dermatitis. J Clin Aesthet Dermatol. 2011;4(11):39-41.
8. Mortz CG, Lauritsen JM, Bindslev-Jensen C, Andersen KE. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Br J Dermatol. 2001;144 (3):523-32. (Pubitemid 32232006)
9. Goebeler M, Trautmann A, Voss A, Brocker EV, Toksoy A, Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol. 2001;158(2):431-40. (Pubitemid 32158606)
10. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol. 2004;14(3):131-8. (Pubitemid 38738449)
11. Belhadjali H, Mohamed M, Youssef M, Mandhouj S, Chakroun M, Zili J. Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia. Contact Dermatitis. 2008;58 (3):188-9. (Pubitemid 351248568)
12. Astner S, Gonzalez E, Cheung AC, et al. Non-invasive evaluation of the kinetics of allergic and irritant contact dermatitis. J Invest Dermatol. 2005;124(2):351-9. (Pubitemid 40175882)
13. Brasch J, Burgard J, Sterry W. Common pathogenetic pathways in allergic and irritant contact dermatitis. J Invest Dermatol. 1992;98 (2):166-70.
14. Belloni Fortina A, Romano I, Peserico A, Eichenfield LF. Contact sensitization in very young children. J Am Acad Dermatol. 2011;65(4):772-779.
15. Litvinov IV, Sugathan P, Cohen BA. Recognizing and treating toiletseat contact dermatitis in children. Pediatrics. 2010;125(2):e419-22.
16. Matiz C, Jacob SE. Systemic contact dermatitis in children: how an avoidance diet can make a difference. Pediatr Dermatol. 2011;28 (4):368-74.
17. Seidenari S, Giusti F, Pepe P, Mantovani L. Contact sensitization in 1094 children undergoing patch testing over a 7-year period. Pediatr Dermatol. 2005;22(1):1-5. (Pubitemid 40175992)
18. Champion RH, Rook A, Wilkinson DS, Ebling FJG. Rook/Wilkinson/Ebling textbook of dermatology. 6th ed. Oxford Malden, MA: Blackwell Science; 1998.
19. Contact dermatitis: a practice parameter. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2006;97(3 Suppl 2):S1-38.
20. Bonitsis NG, Tatsioni A, Bassioukas K, Ioannidis JP. Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis. Contact Dermatitis. May 2011;64(5):245-257.
21. Heine G, Schnuch A, Uter W, Worm M. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. Contact Dermatitis. 2004;51(3):111-7. (Pubitemid 39423054)
22. Rycroft RJG. Textbook of contact dermatitis. 3rd ed. Berlin New York: Springer; 2001.
23. Fernandez Vozmediano JM, Armario Hita JC. Allergic contact dermatitis in children. J Eur Acad Dermatol Venereol. 2005;19 (1):42-6. (Pubitemid 40268139)
24. Larsson-Stymne B, Widstrom L. Ear piercing-a cause of nickel allergy in schoolgirls? Contact Dermatitis. 1985;13(5):289-93. (Pubitemid 16181522)
25. Rystedt I, Fischer T. Relationship between nickel and cobalt sensitization in hard metal workers. Contact Dermatitis. 1983;9 (3):195-200. (Pubitemid 13079767)
26. Dotterud LK, Falk ES. Metal allergy in north Norwegian schoolchildren and its relationship with ear piercing and atopy. Contact Dermatitis. 1994;31(5):308-13. (Pubitemid 24361106)
27. Christensen OB, Moller H. Nickel allergy and hand eczema. Contact Dermatitis. 1975;1(3):129-35.
28. Veien NK, Hattel T, Laurberg G. Low nickel diet: an open, prospective trial. J Am Acad Dermatol. 1993;29(6):1002-7. (Pubitemid 23360335)
29. Antico A, Soana R. Chronic allergic-like dermatopathies in nickelsensitive patients. Results of dietary restrictions and challenge with nickel salts. Allergy Asthma Proc. 1999;20(4):235-42.
30. Sharma AD. Relationship between nickel allergy and diet. Indian J Dermatol Venereol Leprol. 2007;73(5):307-12.
31. Belsito DV. Thimerosal: contact (non)allergen of the year. Am J Contact Dermat. 2002;13(1):1-2. (Pubitemid 34205621)
32. van't Veen AJ. Vaccines without thiomersal: why so necessary, why so long coming? Drugs. 2001;61(5):565-72.
33. Roul S, Ducombs G, Taieb A. Usefulness of the European standard series for patch testing in children. A 3-year single-centre study of 337 patients. Contact Dermatitis. 1999;40(5):232-5. (Pubitemid 29195156)
34. Trattner A, David M. Patch testing with fine fragrances: comparison with fragrance mix, balsam of Peru and a fragrance series. Contact Dermatitis. 2004;49(6):287-9. (Pubitemid 38446232)
35. Larsen W, Nakayama H, Lindberg M, et al. Fragrance contact dermatitis: a worldwide multicenter investigation (Part I). Am J Contact Dermat. 1996;7(2):77-83. (Pubitemid 26189549)
36. Zug KA, Warshaw EM, Fowler Jr JF, et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis. 2009;20(3):149-60.
37. Hjorth N. Eczematous allergy to balsams, allied perfumes and flavouring agents, with special reference to balsam of Peru. Acta Derm Venereol Suppl (Stockh). 1961;41 Suppl 46:1-216.
38. Bedello PG, Goitre M, Cane D. Contact dermatitis and flare from food flavouring agents. Contact Dermatitis. 1982;8(2):143-4.
39. Salam TN, Fowler Jr JF. Balsam-related systemic contact dermatitis. J Am Acad Dermatol. 2001;45(3):377-81. (Pubitemid 32800492)
40. Veien NK, Hattel T, Justesen O, Norholm A. Reduction of intake of balsams in patients sensitive to balsam of Peru. Contact Dermatitis. 1985;12(5):270-3. (Pubitemid 15069692)
41. Veien NK, Hattel T, Justesen O, Norholm N. Oral challenge with balsam of Peru. Contact Dermatitis. 1985;12(2):104-7. (Pubitemid 15163538)
42. Fisher AA, Rietschel RL, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc.; 2008.
43. Bjarnason B, Flosadottir E. Patch testing with neomycin sulfate. Contact Dermatitis. 2000;43(5):295-302.
44. De U, Pal DK. Seventy cases of non-tubercular psoas abscess at a rural referral centre in South Bengal. Tropical doctor. 2006;36(1):53-4. (Pubitemid 43242245)
45. Kwittken PL, Rosen S, Sweinberg SK. MMR vaccine and neomycin allergy. Am J Dis Child. 1993;147(2):128-9.
46. Paulsen E, Otkjaer A, Andersen KE. Sesquiterpene lactone dermatitis in the young: is atopy a risk factor? Contact Dermatitis. 2008;59(1):1-6. (Pubitemid 351990040)
47. Belloni Fortina A, Romano I, Peserico A. Contact sensitization to Compositae mix in children. J Am Acad Dermatol. 2005;53 (5):877-80. (Pubitemid 41501386)
48. Beattie PE, Green C, Lowe G, Lewis-Jones MS. Which children should we patch test? Clin Exp Dermatol. 2007;32(1):6-11. (Pubitemid 46006357)
49. Jacob SE, Herro EM, Sullivan K, Matiz C, Eichenfield L, Hamann C. Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis. 2011;22(4):204-10.
50. Camacho-Halili M, Axelrod S, Michelis MA, et al. A multi-center, retrospective review of patch testing for contact dermatitis in allergy practices. Ann Allergy Asthma Immunol. 2011;107 (6):487-92.
51. Davis MD, Bhate K, Rohlinger AL, Farmer SA, Richardson DM, Weaver AL. Delayed patch test reading after 5 days: the Mayo Clinic experience. J Am Acad Dermatol. 2008;59(2):225-33.
52. Corazza M, Baldo F, Ricci M, Sarno O, Virgili A. Efficacy of new barrier socks in the treatment of foot allergic contact dermatitis. Acta Derm Venereol. 2011;91(1):68-9.
53. Fonacier LSMB. Contact Dermatitis: Elsevier Saunders; 2010.
54. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006;118(1):152-69. (Pubitemid 43946480)
55. Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology. 2007;215 Suppl 1:45-54. (Pubitemid 350308379)
56. Bekersky I, Fitzsimmons W, Tanase A, Maher RM, Hodosh E, Lawrence I. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol. 2001;44(1 Suppl):S17-27. (Pubitemid 32047910)
57. Belsito D, Wilson DC, Warshaw E, et al. A prospective randomized clinical trial of 0.1%tacrolimus ointment in amodel of chronic allergic contact dermatitis. J Am Acad Dermatol. 2006;55(1):40-6. (Pubitemid 43867046)
58. Katsarou A, Makris M, Papagiannaki K, Lagogianni E, Tagka A, Kalogeromitros D. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol. 2012;22(2):192-6.
59. Mrowietz U, Klein CE, Reich K, et al. Cyclosporine therapy in dermatology. J Dtsch Dermatol Ges. 2009;7(5):474-9.
60. Heller M, Shin HT, Orlow SJ, Schaffer JV. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Br J Dermatol. 2007;157(1):127-32. (Pubitemid 46934265)
61. Simon D. Systemic therapy of atopic dermatitis in children and adults. Curr Probl Dermatol. 2011;41:156-64.
62. Granlund H, Erkko P, Reitamo S. Long-term follow-up of eczema patients treated with cyclosporine. Acta Derm Venereol. 1998;78 (1):40-3. (Pubitemid 28103677)
63. Verma KK, Bansal A, Sethuraman G. Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol. 2006;72(1):24-7. (Pubitemid 43201336)
64. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76(5):371-6. (Pubitemid 26297982)
65. Hon KL, Ching GK, Leung TF, Chow CM, Lee KK, Ng PC. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. J Dermatolog Treat. 2009;20(3):141-5.
66. Brandao MH, Gontijo B, Girundi MA, de Castro MC. Ear piercing as a risk factor for contact allergy to nickel. J Pediatr (Rio J). 2010;86(2):149-54.
67. Jensen CS, Lisby S, Baadsgaard O, Volund A, Menne T. Decrease in nickel sensitization in a Danish schoolgirl population with ears pierced after implementation of a nickel-exposure regulation. Br J Dermatol. 2002;146(4):636-42. (Pubitemid 34437777)
68. Thyssen JP. Nickel and cobalt allergy before and after nickel regulation-evaluation of a public health intervention. Contact Dermatitis. 2011;65 Suppl 1:1-68.
69. Corrente S, Moschese V, Chianca M, et al. Temporary henna tattoo is unsafe in atopic children. Acta Paediatrica. 2007;96(3):469-71. (Pubitemid 46439503)
70. Jacob SE, Zapolanski T, Chayavichitsilp P, Connelly EA, Eichenfield LF. p-Phenylenediamine in black henna tattoos: a practice in need of policy in children. Arch Pediatr Adolesc Med. 2008;162(8):790-2.
71. DeLeo VA. p-Phenylenediamine. Dermatitis. 2006;17(2):53-5.